CClinicalTrials.gg
CompletedNCT07710079Updated Jul 17, 2026

POS Mobilization by 3-DRT Affect Functional Outcome in Layered Syndrome

An interventional study of Conventional Physical Therapy and POS Mobilization in Shoulder Pain, Neck Pain and Low Back Pain, sponsored by Riphah International University. Completed at 1 site in Pakistan. Open to participants aged 20 Years to 40 Years. Per ClinicalTrials.gov, last updated 2026-07-17.

Sponsored by Riphah International University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Dec 2025, registered Jun 2026).
Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
20 Years to 40 Years
Sex
All
01

Study summary

I aim to study the effects of posterior oblique sling mobilization by 3-D release technique on pain, range of motion and functional disability in layered syndrome

Read the detailed description

In previous literature a placebo randomized control trial was conducted. To examine how 3D MFR affects lumbar range of motion and a lumbar lordosis angle in people with asymptomatic hyperlordosis. 30 participants with hyperlordosis who met the inclusion criteria were selected. Using a lottery approach, these individuals were randomly assigned to either the experiemental group or control group, keeping a 1:1 ratio. The experimental group received 3D MFR and the control group received sham 3D MFR for six sessions (3 alternate days for 2 weeks). Lumbar range of motion was assessed using modified-modified Schober's test and the lumbar lordosis angle was measured using x-ray and flexicurve.

02

Conditions studied

  • Shoulder Pain
  • Neck Pain
  • Low Back Pain

Keywords

  • Disability
  • Pain
  • Range of motion
03

In context

Shoulder Pain

707 studies on the registry are indexed under Shoulder Pain; 152 are open to participants now.

This study's enrollment of 44 is below the median of 60 across 561 interventional studies indexed under Shoulder Pain.

Browse Shoulder Pain studies →

Lead sponsor

Riphah International University is the lead sponsor of 2,133 studies on the registry; 633 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 40 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • + Craniocervical flexion test
  • + Fleshe test (Occiput to wall distance)
  • + Thomas test
  • + Straight leg raise (SLR)
  • +Push Up test
  • +Trunk Curl Up test

Exclusion criteria

Exclusion Criteria:

  • Other conditions involving the shoulder (eg. rheumatoid arthritis, osteoarthritis, damage of the glenohumeral cartilage, Hill-Sachs lesion, osteoporosis, or malignancies in the shoulder region).
  • Presence of medical conditions such as cardiac disease, infections, coagulation disorder.
  • The participants with any musculoskeletal injuries in the past 6 months
  • Cervical dysfunctions affecting upper limbs
  • Lumbar Dysfunctions
  • Any fracture or other injury
  • Any systemic illness
  • Any neurological disease
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
44 participants (actual)

Study arms

  • Experimental
    POS mobilization

    Posterior oblique sling mobilization by 3-D release technique along with conventional physiotherapy treatment for Upper cross and lower cross syndrome

    Other: POS Mobilization

  • Active comparator
    Coventional Physical therapy

    Cervical isometrics and stretching, Lumbar isometrics and stretching

    Other: Conventional Physical Therapy

Interventions

  • OtherConventional Physical Therapy

    Cervical isometrics and lumbar isometrics 10 repitionsx 1 set, 3 days/week and targeted sustained muscle stretching (pectoralis, upper trapezius, levator scapulae, iliopsoas, rectus femoris and lumbar erector spinae) for 20-30 seconds 10 repititions x 1 set 3 days/week 12 sessions were given in total

  • OtherPOS Mobilization

    In experimental group, POS mobilization was done along with cervical and lumbar isometrics and stretching. POS mobilization by 3-D release technique along with Cervical isometrics and lumbar isometrics 10 repitionsx 1 set, 3 days/week and targeted sustained muscle stretching (pectoralis, upper trapezius, levator scapulae, iliopsoas, rectus femoris and lumbar erector spinae) for 20-30 seconds 10 repititions x 1 set 3 days/week 12 sessions were given in total

06

What researchers measure

Primary outcomes

  1. Neck disability Index

    Changes from the baseline NDI is a 10-item questionnaire created by Vernon and Mior in 1991 to assess how neck pain affects daily activities such as lifting, reading, driving, personal care, sleeping, recreation, and concentration. On a scale of 0 to 5, each item has a score; higher scores correspond to more disability.

    Time frame: 4rth week

  2. Oswestry Disability Index

    Changes from the baseline Oswestry Disability Index (ODI) is regarded as the gold standard for assessing adults with low back pain (LBP) in terms of both disability and quality of life (QOL). The questionnaire is designed to be a self-reported survey, where patients suffering from LBP come across limitations in Activities of Daily Living (ADL's) in several health constructs like personal care, lifting, walking, sitting, standing, sleeping, sexual life, social life, and traveling. The patients indicated the effect of pain on activities. The questions having a score range from 0 to 5, giving a maximum total score of 50. Oswestry Disability Index (ODI).

    Time frame: 4rth week

  3. Shoulder Pain and Disability Index

    Changes from the baseline SPADI is a self-administered questionnaire designed to evaluate pain and functional impairment related to shoulder disorders. It consists of 13 items, divided into pain and disability subscales, and is often used in both clinical practice and research.

    Time frame: 4rth week

Secondary outcomes

  1. Numeric Pain rating sclae (NPRS)

    Changes from the baseline NPRS consists of an 11-point scale ranging from 0 to 10, where 0 represents "no pain" and 10 indicates the "worst imaginable pain."

    Time frame: 4rth week

  2. ROM Cervical Spine (Flexion)

    Changes from the baseline ROM range of cervical spine flexion was taken

    Time frame: 4rth week

  3. ROM Cervical Spine (Extension)

    Changes from the baseline ROM range of cervical spine extension was taken

    Time frame: 4rth

  4. ROM Cervical Spine (Lateral Flexion)

    Changes from the baseline ROM range of cervical spine lateral flexion was taken

    Time frame: 4rth

  5. ROM Lumbar Spine (Flexion)

    Changes from the baseline ROM range of lumbar spine flexion was taken

    Time frame: 4rth

  6. ROM Lumbar Spine (Extension)

    Changes from the baseline ROM range of lumbar spine extension was taken

    Time frame: 4rth

  7. ROM Shoulder joint (Flexion)

    Changes from the baseline ROM range of shoulder joint flexion was taken

    Time frame: 4rth

  8. ROM Shoulder joint (Abduction)

    Changes from the baseline ROM range of shoulder joint abduction was taken

    Time frame: 4rth

  9. ROM Shoulder joint (External Rotation)

    Changes from the baseline ROM range of shoulder joint external rotation was taken

    Time frame: 4rth

07

Study locations

1 site
  • Imran Idrees teachingHospital
    Sialkot, Punjab Province 51310, Pakistan
08

References and documents

Publications

  • Welling A, Patil A, Gunjal P, Naik P, Hubli R. Effectiveness of Three-Dimensional Myofascial Release on Lumbar Lordosis in Individuals with Asymptomatic Hyperlordosis: A Placebo Randomized Controlled Trial. Int J Ther Massage Bodywork. 2024 Jun 13;17(2):20-31. doi: 10.3822/ijtmb.v17i2.957. eCollection 2024 Jun. PubMed 38873188 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 17, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07710079
Lead sponsor
Riphah International University
Responsible party
Sponsor
First posted
Jul 17, 2026
Start date
Dec 1, 2025
Primary completion
May 1, 2026
Completion
May 1, 2026
Last update
Jul 17, 2026

Study contacts

Saba Rafique, Phd*
principal investigator · Riphah International University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion